| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |